Exact Mass: 423.0757714

Exact Mass Matches: 423.0757714

Found 22 metabolites which its exact mass value is equals to given mass value 423.0757714, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Xanthommatin

Xanthommatin

C20H13N3O8 (423.0702618)


An ommochrome that consists of a pyrido[3,2-a]phenoxazine ring system bearing hydroxy, carboxy, oxo and 3-amino-3-carboxypropanoyl substituents at positions 1, 3, 5 and 11 respectively. The parent of the class of xanthommatins.

   
   

N-(4-Sulfophenyl)adenosine

4-({9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)benzene-1-sulphonic acid

C16H17N5O7S (423.0848652)


   

Phtpp

4-(2-Phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol

C20H11F6N3O (423.0806268)


   

Ethyl 3-cyano-6-methyl-2-({2-[(2-thienylcarbonyl)amino]phenyl}thio)isonicotinate

Ethyl 3-cyano-6-methyl-2-({2-[(2-thienylcarbonyl)amino]phenyl}thio)isonicotinate

C21H17N3O3S2 (423.07112920000003)


   
   
   
   

2-([4-(2-Chlorophenyl)-3-ethoxycarbonyl-6-hydroxymethyl-2-picolinyl]methoxyacetic acid

2-([4-(2-Chlorophenyl)-3-ethoxycarbonyl-6-hydroxymethyl-2-picolinyl]methoxyacetic acid

C19H18ClNO8 (423.0720898)


   
   

Sodium 4,4-(m-tolylazanediyl)bis(butane-1-sulfonate)

Sodium 4,4-(m-tolylazanediyl)bis(butane-1-sulfonate)

C15H23NNa2O6S2 (423.0762138)


   

Cefuroxime Sodium EP Impurity G

Cefuroxime Sodium EP Impurity G

C17H17N3O8S (423.0736322)


   

(11Z)-11-(3-azaniumyl-3-carboxylato-1-oxidopropylidene)-1,5-dioxo-4,12a-dihydropyrido[3,2-a]phenoxazine-3-carboxylate

(11Z)-11-(3-azaniumyl-3-carboxylato-1-oxidopropylidene)-1,5-dioxo-4,12a-dihydropyrido[3,2-a]phenoxazine-3-carboxylate

C20H13N3O8-2 (423.0702618)


   

tetrakis(pyridine)silver(II)

tetrakis(pyridine)silver(II)

C20H20AgN4 (423.073883)


   

5-Bromo-3-[[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester

5-Bromo-3-[[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester

C18H22BrN3O4 (423.07935920000006)


   

methyl 2-[(4-fluoro-2-nitrophenyl)carbamothioylamino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate

methyl 2-[(4-fluoro-2-nitrophenyl)carbamothioylamino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate

C18H18FN3O4S2 (423.07227200000005)


   

N-{[5-(1,3-benzothiazol-2-ylsulfanyl)-2-furyl]methylene}-2-(2-methylphenoxy)acetohydrazide

N-{[5-(1,3-benzothiazol-2-ylsulfanyl)-2-furyl]methylene}-2-(2-methylphenoxy)acetohydrazide

C21H17N3O3S2 (423.07112920000003)


   

4-[[9-[(2R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-6-purinyl]amino]benzenesulfonic acid

4-[[9-[(2R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-6-purinyl]amino]benzenesulfonic acid

C16H17N5O7S (423.0848652)


   

4-[(2E)-2-[(1-phenyl-3-thiophen-2-ylpyrazol-4-yl)methylidene]hydrazinyl]benzenesulfonamide

4-[(2E)-2-[(1-phenyl-3-thiophen-2-ylpyrazol-4-yl)methylidene]hydrazinyl]benzenesulfonamide

C20H17N5O2S2 (423.0823622)


   

PXL770

PXL770

C23H18ClNO3S (423.0695868)


PXL770 is a direct AMP kinase activator. PXL770 can be used in the research of non-alcoholic fatty liver disease (NAFLD)[1].

   

ZK53

ZK53

C19H20BrF2N3O (423.0757714)


ZK53 is a selective activator of mitochondrial caseinolytic protease P (HsClpP) (EC50: 1.37?μM for α-casein hydrolysis by HsClpP). ZK53 is is inactive toward bacterial ClpP proteins. ZK53 induces apoptosis in H1703, H520 and SK-MES-1 cells. ZK53 induces dysregulation of mitochondrial functions in lung squamous cell carcinoma (LUSC) cells. ZK53 inhibits tumor growth in H1703 xenograft mouse model[1].